230 related articles for article (PubMed ID: 20516645)
21. PTEN signaling pathways in melanoma.
Wu H; Goel V; Haluska FG
Oncogene; 2003 May; 22(20):3113-22. PubMed ID: 12789288
[TBL] [Abstract][Full Text] [Related]
22. Increased Rac activity is required for the progression of T-lymphomas induced by Pten-deficiency.
Strumane K; Song JY; Baas I; Collard JG
Leuk Res; 2008 Jan; 32(1):113-20. PubMed ID: 17521720
[TBL] [Abstract][Full Text] [Related]
23. The phosphatidylinositol phosphatase PTEN is under control of costimulation and regulates proliferation in human T cells.
Schmidt-Weber CB; Wohlfahrt JG; Akdis CA; Blaser K
Eur J Immunol; 2002 Apr; 32(4):1196-204. PubMed ID: 11932928
[TBL] [Abstract][Full Text] [Related]
24. Splenic marginal zone B-cell and thymic T-cell lymphomas in p53-deficient mice.
Ward JM; Tadesse-Heath L; Perkins SN; Chattopadhyay SK; Hursting SD; Morse HC
Lab Invest; 1999 Jan; 79(1):3-14. PubMed ID: 9952106
[TBL] [Abstract][Full Text] [Related]
25. Activation of synovial fibroblasts in rheumatoid arthritis: lack of Expression of the tumour suppressor PTEN at sites of invasive growth and destruction.
Pap T; Franz JK; Hummel KM; Jeisy E; Gay R; Gay S
Arthritis Res; 2000; 2(1):59-64. PubMed ID: 11219390
[TBL] [Abstract][Full Text] [Related]
26. Abnormal rearrangement within the alpha/delta T-cell receptor locus in lymphomas from Atm-deficient mice.
Liyanage M; Weaver Z; Barlow C; Coleman A; Pankratz DG; Anderson S; Wynshaw-Boris A; Ried T
Blood; 2000 Sep; 96(5):1940-6. PubMed ID: 10961898
[TBL] [Abstract][Full Text] [Related]
27. PTEN gene alterations in lymphoid neoplasms.
Sakai A; Thieblemont C; Wellmann A; Jaffe ES; Raffeld M
Blood; 1998 Nov; 92(9):3410-5. PubMed ID: 9787181
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of Ras, Raf and L-myc but not Bcl-2 family proteins is linked with resistance to TCR-mediated apoptosis and tumorigenesis in thymic lymphomas from TCR transgenic mice.
Kobzdej M; Matuszyk J; Strzadala L
Leuk Res; 2000 Jan; 24(1):33-8. PubMed ID: 10634643
[TBL] [Abstract][Full Text] [Related]
29. Rearrangement of the T-cell receptor delta chain gene in T-cell lymphomas with a mature phenotype.
van Krieken JH; Elwood L; Andrade RE; Jaffe ES; Cossman J; Medeiros LJ
Am J Pathol; 1991 Jul; 139(1):161-8. PubMed ID: 1830192
[TBL] [Abstract][Full Text] [Related]
30. Increased phosphoinositide 3-kinase activity induces a lymphoproliferative disorder and contributes to tumor generation in vivo.
Borlado LR; Redondo C; Alvarez B; Jimenez C; Criado LM; Flores J; Marcos MA; Martinez-A C; Balomenos D; Carrera AC
FASEB J; 2000 May; 14(7):895-903. PubMed ID: 10783143
[TBL] [Abstract][Full Text] [Related]
31. The evolution of thymic lymphomas in p53 knockout mice.
Dudgeon C; Chan C; Kang W; Sun Y; Emerson R; Robins H; Levine AJ
Genes Dev; 2014 Dec; 28(23):2613-20. PubMed ID: 25452272
[TBL] [Abstract][Full Text] [Related]
32. Myeloid, B and T lymphoid and mixed lineage thymic lymphomas in the irradiated mouse.
Boulton E; Cleary H; Plumb M
Carcinogenesis; 2002 Jun; 23(6):1079-85. PubMed ID: 12082032
[TBL] [Abstract][Full Text] [Related]
33. PD-1 is a haploinsufficient suppressor of T cell lymphomagenesis.
Wartewig T; Kurgyis Z; Keppler S; Pechloff K; Hameister E; Öllinger R; Maresch R; Buch T; Steiger K; Winter C; Rad R; Ruland J
Nature; 2017 Dec; 552(7683):121-125. PubMed ID: 29143824
[TBL] [Abstract][Full Text] [Related]
34. Tp53 deletion in B lineage cells predisposes mice to lymphomas with oncogenic translocations.
Rowh MA; DeMicco A; Horowitz JE; Yin B; Yang-Iott KS; Fusello AM; Hobeika E; Reth M; Bassing CH
Oncogene; 2011 Nov; 30(47):4757-64. PubMed ID: 21625223
[TBL] [Abstract][Full Text] [Related]
35. Mouse germline transcript of TCR alpha joining region and temporal expression in ontogeny.
Shimizu T; Takeshita S; Muto M; Kubo E; Sado T; Yamagishi H
Int Immunol; 1993 Feb; 5(2):155-60. PubMed ID: 8383995
[TBL] [Abstract][Full Text] [Related]
36. Loss of Setd4 delays radiation-induced thymic lymphoma in mice.
Feng X; Lu H; Yue J; Schneider N; Liu J; Denzin LK; Chan CS; De S; Shen Z
DNA Repair (Amst); 2020 Feb; 86():102754. PubMed ID: 31794893
[TBL] [Abstract][Full Text] [Related]
37. A chromosome 14q11/TCR alpha/delta specific yeast artificial chromosome improves the detection rate and characterization of chromosome abnormalities in T-lymphoproliferative disorders.
Rack KA; Cornélis F; Radford-Weiss I; Bernheim A; Harrison CJ; Hermine O; Prieur M; Vekemans M; Macintyre EA
Blood; 1997 Aug; 90(3):1233-40. PubMed ID: 9242557
[TBL] [Abstract][Full Text] [Related]
38. Evidence of a possible epigenetic inactivation mechanism operating on a region of mouse chromosome 19 in gamma-radiation-induced thymic lymphomas.
Santos J; Herranz M; Fernández M; Vaquero C; López P; Fernández-Piqueras J
Oncogene; 2001 Apr; 20(17):2186-9. PubMed ID: 11360203
[TBL] [Abstract][Full Text] [Related]
39. Aberrant V(D)J recombination is not required for rapid development of H2ax/p53-deficient thymic lymphomas with clonal translocations.
Bassing CH; Ranganath S; Murphy M; Savic V; Gleason M; Alt FW
Blood; 2008 Feb; 111(4):2163-9. PubMed ID: 17855626
[TBL] [Abstract][Full Text] [Related]
40. Differential requirements for c-Myc in chronic hematopoietic hyperplasia and acute hematopoietic malignancies in Pten-null mice.
Zhang J; Xiao Y; Guo Y; Breslin P; Zhang S; Wei W; Zhang Z; Zhang J
Leukemia; 2011 Dec; 25(12):1857-68. PubMed ID: 21926961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
